Literature DB >> 33623549

Clinical presentation, case management and outcomes for the first 32 COVID-19 patients in Nigeria.

Abimbola Bowale1, Akin Abayomi2, Jide Idris2, Sunday Omilabu3, Ismail Abdus-Salam2, Busayo Adebayo4, Folarin Opawoye5, Ore Finnih-Awokoya6, Emmanuella Zamba2, Hussein Abdur-Razzaq2, Olufemi Erinoso4, Tosin Onasanya7, Patrick Ramadan8, Sam Nyenyi8, Evaristus Aniaku9, Muhammad Balogun10, Oyeladun Okunromade9, Olusola Adejumo1, Sunday Adesola1, Tope Ogunniyan1, Mobolanle Balogun3,5, Akin Osibogun3,7.   

Abstract

INTRODUCTION: Success in curtailing the pandemic coronavirus disease (COVID-19) depends largely on a sound understanding of the epidemiologic and clinical profile of cases in a population as well as the case management approach. This study documents the presenting characteristics, treatment modalities and outcomes of the first 32 COVID-19 patients in Nigeria.
METHODS: This retrospective study used medical records of the first 32 patients admitted and discharged from the Mainland Hospital, Lagos State, southwest Nigeria between February 27 and April 6, 2020. The outcomes of interest were death, promptness of admission process and duration of hospitalization.
RESULTS: The mean age of the patients was 38.1 years (SD: 15.5) and 66% were male. Three-quarters (75%) of the patients presented in moderately severe condition while 16% were asymptomatic. The most common presenting symptoms were fever (59%) and dry cough (44%). The mean time between a positive test result and admission was 1.63 days (SD: 1.31). Almost all (97%) the patients were treated with lopinavir-ritonavir with no recorded death. The median duration of hospital stay was 12 days (IQR: 9-13.5).
CONCLUSION: In this preliminary analysis of the first COVID-19 cases in Nigeria, clinical presentation was mild to moderate with no mortality. Processes to improve promptness of admission and reduce hospital stay are required to enhance the response to COVID-19 in Nigeria. ©Abimbola Bowale et al.

Entities:  

Keywords:  COVID-19 presentation; Nigeria; clinical outcomes; retrospective study

Mesh:

Year:  2020        PMID: 33623549      PMCID: PMC7875732          DOI: 10.11604/pamj.supp.2020.35.2.23262

Source DB:  PubMed          Journal:  Pan Afr Med J


  18 in total

1.  COVID-19-New Insights on a Rapidly Changing Epidemic.

Authors:  Carlos Del Rio; Preeti N Malani
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

2.  Presumed Asymptomatic Carrier Transmission of COVID-19.

Authors:  Yan Bai; Lingsheng Yao; Tao Wei; Fei Tian; Dong-Yan Jin; Lijuan Chen; Meiyun Wang
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

3.  Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis.

Authors:  Yong Hu; Jiazhong Sun; Zhe Dai; Haohua Deng; Xin Li; Qi Huang; Yuwen Wu; Li Sun; Yancheng Xu
Journal:  J Clin Virol       Date:  2020-04-14       Impact factor: 3.168

4.  Smell and taste dysfunction in patients with COVID-19.

Authors:  Michael S Xydakis; Puya Dehgani-Mobaraki; Eric H Holbrook; Urban W Geisthoff; Christian Bauer; Charlotte Hautefort; Philippe Herman; Geoffrey T Manley; Dina M Lyon; Claire Hopkins
Journal:  Lancet Infect Dis       Date:  2020-04-15       Impact factor: 25.071

5.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.

Authors: 
Journal:  Nat Microbiol       Date:  2020-03-02       Impact factor: 17.745

6.  Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis.

Authors:  Pengfei Sun; Shuyan Qie; Zongjian Liu; Jizhen Ren; Kun Li; Jianing Xi
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 20.693

7.  A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.

Authors:  Bin Cao; Yeming Wang; Danning Wen; Wen Liu; Jingli Wang; Guohui Fan; Lianguo Ruan; Bin Song; Yanping Cai; Ming Wei; Xingwang Li; Jiaan Xia; Nanshan Chen; Jie Xiang; Ting Yu; Tao Bai; Xuelei Xie; Li Zhang; Caihong Li; Ye Yuan; Hua Chen; Huadong Li; Hanping Huang; Shengjing Tu; Fengyun Gong; Ying Liu; Yuan Wei; Chongya Dong; Fei Zhou; Xiaoying Gu; Jiuyang Xu; Zhibo Liu; Yi Zhang; Hui Li; Lianhan Shang; Ke Wang; Kunxia Li; Xia Zhou; Xuan Dong; Zhaohui Qu; Sixia Lu; Xujuan Hu; Shunan Ruan; Shanshan Luo; Jing Wu; Lu Peng; Fang Cheng; Lihong Pan; Jun Zou; Chunmin Jia; Juan Wang; Xia Liu; Shuzhen Wang; Xudong Wu; Qin Ge; Jing He; Haiyan Zhan; Fang Qiu; Li Guo; Chaolin Huang; Thomas Jaki; Frederick G Hayden; Peter W Horby; Dingyu Zhang; Chen Wang
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

8.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.

Authors:  Chih-Cheng Lai; Tzu-Ping Shih; Wen-Chien Ko; Hung-Jen Tang; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2020-02-17       Impact factor: 5.283

9.  Treatment of COVID-19: old tricks for new challenges.

Authors:  Anne Catherine Cunningham; Hui Poh Goh; David Koh
Journal:  Crit Care       Date:  2020-03-16       Impact factor: 9.097

Review 10.  World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).

Authors:  Catrin Sohrabi; Zaid Alsafi; Niamh O'Neill; Mehdi Khan; Ahmed Kerwan; Ahmed Al-Jabir; Christos Iosifidis; Riaz Agha
Journal:  Int J Surg       Date:  2020-02-26       Impact factor: 6.071

View more
  14 in total

1.  Early geography of the coronavirus disease outbreak in Nigeria.

Authors:  Adeyemi Olusola; Babatunde Olusola; Olumide Onafeso; Felix Ajiola; Samuel Adelabu
Journal:  GeoJournal       Date:  2020-08-13

2.  Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria.

Authors:  Akin Abayomi; Oluwakemi Odukoya; Akin Osibogun; Ololade Wright; Bisola Adebayo; Mobolanle Balogun; Ismael Abdus-Salam; Abimbola Bowale; Bamidele Mutiu; Babatunde Saka; Moyosore Adejumo; Sam Yenyi; Rotimi Agbolagorite; Oluwatosin Onasanya; Eniola Erinosho; Joshua Obasanya; Olu Adejumo; Sunday Adesola; Yewande Oshodi; Iorhen E Akase; Shina Ogunbiyi; Dayo Lajide; Femi Erinoso; Hussein Abdur-Razzaq
Journal:  Int J Infect Dis       Date:  2020-10-16       Impact factor: 3.623

3.  Views and experiences of discharged COVID-19 patients in Kano, Nigeria: a qualitative study.

Authors:  Naziru Bashir Mukhtar; Auwal Abdullahi; Muhammad Aliyu Abba; Jibril Mohammed
Journal:  Pan Afr Med J       Date:  2020-11-17

4.  Clinical and laboratory characteristics of COVID-19 among adult patients admitted to the isolation centre at Abubakar Tafawa Balewa Teaching Hospital Bauchi, Northeast Nigeria.

Authors:  Yusuf Bara Jibrin; Okon Kenneth Okwong; Ibrahim Mahmood Maigari; Jacob Amos Dunga; Abubakar Muhammad Ballah; Mustapha Sabo Umar; Alkali Mohammed; Zuwaira Ibrahim Hassan
Journal:  Pan Afr Med J       Date:  2020-10-22

5.  Clinical and epidemiological characteristics of 646 hospitalised SARS-Cov-2 positive patients in Rivers State Nigeria: a prospective observational study.

Authors:  Datonye Alasia; Golden Owhonda; Omosivie Maduka; Ifeoma Nwadiuto; Godswill Arugu; Charles Tobin-West; Esther Azi; Victor Oris-Onyiri; Inwon Joseph Urang; Victor Abikor; Ayo-Maria Olofinuka; Obelebra Adebiyi; Abiye Somiari; Hope Avundaa; Aloni Alali
Journal:  Pan Afr Med J       Date:  2021-01-12

6.  'Long COVID': persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria.

Authors:  Bodunrin Osikomaiya; Olufemi Erinoso; Kikelomo Ololade Wright; Aina Olufemi Odusola; Babafemi Thomas; Oluwatosin Adeyemi; Abimbola Bowale; Olusola Adejumo; Ayodeji Falana; Ismail Abdus-Salam; Olusegun Ogboye; Akin Osibogun; Akin Abayomi
Journal:  BMC Infect Dis       Date:  2021-03-25       Impact factor: 3.090

7.  Clinical characteristics of 4499 COVID-19 patients in Africa: A meta-analysis.

Authors:  Testimony Jesupamilerin Olumade; Leonard Ighodalo Uzairue
Journal:  J Med Virol       Date:  2021-02-12       Impact factor: 20.693

8.  Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.

Authors:  Akin Abayomi; Akin Osibogun; Oluchi Kanma-Okafor; Jide Idris; Abimbola Bowale; Ololade Wright; Bisola Adebayo; Mobolanle Balogun; Segun Ogboye; Remi Adeseun; Ismael Abdus-Salam; Bamidele Mutiu; Babatunde Saka; Dayo Lajide; Sam Yenyi; Rotimi Agbolagorite; Oluwatosin Onasanya; Eniola Erinosho; Joshua Obasanya; Olu Adejumo; Sunday Adesola; Yewande Oshodi; Iorhen E Akase; Shina Ogunbiyi; Adenike Omosun; Femi Erinoso; Hussein Abdur-Razzaq; Nike Osa; Kingsley Akinroye
Journal:  Glob Health Res Policy       Date:  2021-07-29

9.  Psychosocial health effects of Covid-19 infection on persons in treatment centers in Lagos, Nigeria.

Authors:  Babatunde Fadipe; Yewande O Oshodi; Charles Umeh; Kehinde Aikomo; Omotayo Francis Ajirotutu; Jaiyeola Kajero; Chizoba Fashanu; Adefemi A Adeoye; Ayodele Olurotimi Coker; Modupe Sokunbi; Veronica Oluyemisi Nyamali; Tolu Ajomale; Adesoji Gbadebo; Adedapo Oni; Ajibola Oladimeji Keshinro; Teniola Anne Ngozi Ejiegbu; Abimbola Bowale; Iorhen E Akase; Bamidele Mutiu; Bisola Adebayo; Ismail Abdus-Salam; Chris Bode; Akin Osibogun
Journal:  Brain Behav Immun Health       Date:  2021-06-15

10.  Epidemiology of COVID-19 and Predictors of Outcome in Nigeria: A Single-Center Study.

Authors:  Olayinka Rasheed Ibrahim; Bello Muhammed Suleiman; Suleiman Bello Abdullahi; Taofeek Oloyede; Abdallah Sanda; Maruf Sanusi Gbadamosi; Bashir Olajide Yusuf; Rabilu Yandoma Iliyasu; Lawal Magaji Ibrahim; Adamu Danladi Dawud; Sulaiman Saidu Bashir; Nwawueze Efam Okonta; Wasinda Francis Umar; Abiodun Gbenga Tekobo; Muhammadu Sani Abubakar; Bashir Taiye Aminu; Shuaibu Onoruoyiza Ibrahim; Rasaq Olaosebikan; Olugbenga Ayodeji Mokuolu
Journal:  Am J Trop Med Hyg       Date:  2020-10-26       Impact factor: 3.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.